Cardiovascular: Stroke Circulatory System Stroke, not specified as haemorrhage or infarction
Conditions
Interventions
All patients will receive botulinum toxin as usual. This is a randomised, single-blind, placebo controlled study. Patients will be randomised to receiving placebo (upper limb splint), or one of two ty
Sponsors
Department of Health (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A minimum of 26 patients post stroke. This will include males and females. All patients will be 20-80 years and there will be a mixture of inpatients and outpatients.
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Activities of daily life; Quality of Life measure; Action research arm test; Fugl-Meyer and other similar measures. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed